This is getting beyond scary:
Surescripts LLC, a provider of the technology widely used to route electronic prescriptions, accused Amazon’s mail-order pharmacy subsidiary PillPack of receiving patient data that it had fraudulently obtained through a third party.
Looks like Amazon is doing whatever it can to break into the market but their competitors have too much to lose to just bend over.
The dispute with Surescripts is an example of the challenges that PillPack faces in disrupting the $424 billion U.S. prescription drug market: In many cases, PillPack’s competitors are also gatekeepers that control access to patient data and payment rates from insurers.
You read that right, $424 BILLION!! Compare that to economies of countries around the world. So, why should something so trivial as your patient data be a hurdle in getting some of this cash? The answer is that it won’t.